(Q44614902)

4 December 2017

title

Disposition of flurbiprofen in man: influence of stereochemistry and age (English)

1 reference

https://api.crossref.org/works/10.1080/00498250310001602739

20 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14555340

20 March 2024

1 reference

https://api.crossref.org/works/10.1080/00498250310001602739

20 March 2024

1 reference

https://api.crossref.org/works/10.1080/00498250310001602739

20 March 2024

author name string

Jackson SH

2

1 reference

4 December 2017

B. K. Patel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14555340

20 March 2024

S. H D. Jackson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14555340

20 March 2024

C. G. Swift

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14555340

20 March 2024

A. J. Hutt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14555340

20 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

http://www.tandfonline.com/doi/pdf/10.1080/00498250310001602739

1 reference

https://api.crossref.org/works/10.1080/00498250310001602739

20 March 2024

1 reference

4 December 2017

volume

33

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1043-1057

1 reference

Pharmacokinetic comparison of flurbiprofen in end-stage renal disease subjects and subjects with normal renal function

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Pharmacokinetic profile of controlled release ketoprofen in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Stereoselective arylpropionyl-CoA thioester formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Stereoselective disposition of flurbiprofen in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Stereoselective disposition of flurbiprofen in uraemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Antiproliferative effects of the enantiomers of flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

The Disposition and Metabolism of Flurbiprofen in Several Species Including Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Influence of H2 receptor antagonists on the disposition of flurbiprofen enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Studies of flurbiprofen 4'-hydroxylation. Additional evidence suggesting the sole involvement of cytochrome P450 2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Role of cytochrome P450 2C9 and an allelic variant in the 4'-hydroxylation of (R)- and (S)-flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Plasma protein binding of drugs in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Treatment and survival study in the C57BL/6J-APC(Min)/+(Min) mouse with R-flurbiprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

The pharmacokinetics of the enantiomers of flurbiprofen in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

A multiple dose pharmacokinetic and tolerance study of once daily 200 mg sustained-release flurbiprofen capsules in young and very elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Stereoselective pharmacokinetics of flurbiprofen in humans and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Comparative bioavailability of two flurbiprofen products: stereospecific versus conventional approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

The Pharmacokinetics of Flurbiprofen in Younger and Elderly Patients with Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Metabolic chiral inversion of flurbiprofen-CoA in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Pharmacokinetics of flurbiprofen in man. I. Area/dose relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Rac-flurbiprofen is more ulcerogenic than its (S)-enantiomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250310001602739

Drug Metabolism and Disposition

21 January 2018

4

23

343

HAMDOUNE M.

1995

1 reference

https://api.crossref.org/works/10.1080/00498250310001602739

Sensitive and specific high-performance liquid chromatographic assay for 4'-hydroxyflurbiprofen and flurbiprofen in human urine and plasma

20 March 2024

8

1 reference

https://api.crossref.org/works/10.1080/00498250310001602739

Drug Metabolism and Disposition

20 March 2024

14

19

280

KNADLER M. P.

1991

1 reference

https://api.crossref.org/works/10.1080/00498250310001602739

Journal of Pharmacology and Experimental Therapeutics

20 March 2024

15

249

378

KNADLER M. P.

1989

1 reference

https://api.crossref.org/works/10.1080/00498250310001602739

Journal of Pharmacology and Experimental Therapeutics

20 March 2024

27

273

88

RUDY A. C.

1995

1 reference

https://api.crossref.org/works/10.1080/00498250310001602739

International Journal of Clinical Pharmacology and Therapeutics

20 March 2024

29

35

1

SURI A.

1997

1 reference

https://api.crossref.org/works/10.1080/00498250310001602739

20 March 2024

Identifiers

1 reference

4 December 2017

1 reference